A machine learning-based gene signature of response to the novel alkylating agent LP-184 distinguishes its potential tumor indications

Abstract excerpt

BACKGROUND: Non-targeted cytotoxics with anticancer activity are often developed through preclinical stages using response criteria observed in cell lines and xenografts. A panel of the NCI-60 cell lines is frequently the first line to define tumor types that are optimally responsive. Open data on the gene expression of the NCI-60 cell lines, provides a unique opportunity to add another dimension to the...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Gene expression and cancer classification
• Share to HER2/EGFR in Cancer Research
• Share to Peptidase Inhibition and Analysis